{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T04:16:58Z","timestamp":1772165818066,"version":"3.50.1"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,1,3]],"date-time":"2025-01-03T00:00:00Z","timestamp":1735862400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,1,3]],"date-time":"2025-01-03T00:00:00Z","timestamp":1735862400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Psychiatry"],"DOI":"10.1186\/s12888-024-06451-2","type":"journal-article","created":{"date-parts":[[2025,1,3]],"date-time":"2025-01-03T04:23:41Z","timestamp":1735878221000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Psychotropic medications: a descriptive study of prescription trends in Tabriz, Iran, 2021\u20132022"],"prefix":"10.1186","volume":"25","author":[{"given":"Mostafa","family":"Farahbakhsh","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ali","family":"Fakhari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ali","family":"Azimian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amin","family":"Khameneh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mahsa","family":"Matinkia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-5559-479X","authenticated-orcid":false,"given":"Ehsan","family":"Aghajani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,1,3]]},"reference":[{"key":"6451_CR1","unstructured":"Organization WH. Mental Disorders. 2022; Available from: World Health Organization. (2022, June 8). Mental disorders. Retrieved from https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/mental-disorders#:~:text=In%202019%2C%201%20in%20every,of%20the%20COVID%2D19%20pandemic"},{"issue":"1","key":"6451_CR2","doi-asserted-by":"publisher","first-page":"21","DOI":"10.4103\/ijpvm.IJPVM_510_18","volume":"11","author":"MT Mirghaed","year":"2020","unstructured":"Mirghaed MT, Gorji HA, Panahi S. Prevalence of psychiatric disorders in Iran: a systematic review and meta-analysis. Int J Prev Med. 2020;11(1):21.","journal-title":"Int J Prev Med"},{"key":"6451_CR3","doi-asserted-by":"publisher","first-page":"592467","DOI":"10.3389\/fpsyt.2020.592467","volume":"11","author":"MH Brenner","year":"2020","unstructured":"Brenner MH, Bhugra D. Acceleration of anxiety, depression, and suicide: secondary effects of economic disruption related to COVID-19. Front Psychiatry. 2020;11:592467.","journal-title":"Front Psychiatry"},{"issue":"3","key":"6451_CR4","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1111\/jcpp.12381","volume":"56","author":"GV Polanczyk","year":"2015","unstructured":"Polanczyk GV, et al. Annual research review: a meta-analysis of the worldwide prevalence of mental disorders in children and adolescents. J Child Psychol Psychiatry. 2015;56(3):345\u201365.","journal-title":"J Child Psychol Psychiatry"},{"issue":"suppl 2","key":"6451_CR5","first-page":"153","volume":"31","author":"A Ka\u0161telan","year":"2019","unstructured":"Ka\u0161telan A, et al. Prescribing patterns in adolescent psychiatric practice: an important role of antipsychotics. Psychiatria Danubina. 2019;31(suppl 2):153\u201361.","journal-title":"Psychiatria Danubina"},{"key":"6451_CR6","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1007\/s00228-009-0679-7","volume":"65","author":"A Clavenna","year":"2009","unstructured":"Clavenna A, Bonati M. Drug prescriptions to outpatient children: a review of the literature. Eur J Clin Pharmacol. 2009;65:749\u201355.","journal-title":"Eur J Clin Pharmacol"},{"issue":"10","key":"6451_CR7","doi-asserted-by":"publisher","first-page":"824","DOI":"10.1016\/S2215-0366(18)30293-1","volume":"5","author":"SR Raman","year":"2018","unstructured":"Raman SR, et al. Trends in attention-deficit hyperactivity disorder medication use: a retrospective observational study using population-based databases. Lancet Psychiatry. 2018;5(10):824\u201335.","journal-title":"Lancet Psychiatry"},{"key":"6451_CR8","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1016\/j.schres.2024.03.047","volume":"267","author":"G Ho","year":"2024","unstructured":"Ho G, et al. Factors impacting intent to seek treatment within youth at clinical high risk for psychosis. Schizophr Res. 2024;267:273\u201381.","journal-title":"Schizophr Res"},{"issue":"3","key":"6451_CR9","doi-asserted-by":"publisher","first-page":"246","DOI":"10.18553\/jmcp.2020.26.3.246","volume":"26","author":"NJ Pauly","year":"2020","unstructured":"Pauly NJ, et al. Trends in gabapentin prescribing in a commercially insured US adult population, 2009\u20132016. J Managed care Specialty Pharm. 2020;26(3):246\u201352.","journal-title":"J Managed care Specialty Pharm"},{"key":"6451_CR10","doi-asserted-by":"crossref","unstructured":"Green K et al. Prescribing trends of gabapentin, Pregabalin, and oxycodone: a secondary analysis of primary care prescribing patterns in England. BJGP open, 2019. 3(3).","DOI":"10.3399\/bjgpopen19X101662"},{"key":"6451_CR11","doi-asserted-by":"crossref","unstructured":"Heald AH, et al. Antidepressant prescribing in England: patterns and costs. Volume 22. The Primary Care Companion for CNS Disorders; 2020. p. 26631. 2.","DOI":"10.4088\/PCC.19m02552"},{"issue":"12","key":"6451_CR12","doi-asserted-by":"publisher","first-page":"e006135","DOI":"10.1136\/bmjopen-2014-006135","volume":"4","author":"L Marston","year":"2014","unstructured":"Marston L, et al. Prescribing of antipsychotics in UK primary care: a cohort study. BMJ open. 2014;4(12):e006135.","journal-title":"BMJ open"},{"key":"6451_CR13","doi-asserted-by":"crossref","unstructured":"Villalobos-Madriz JA et al. Prescribing trends in psychotropic medications among outpatients of a latin American Healthcare setting: a five-year retrospective study. Cureus, 2023. 15(4).","DOI":"10.7759\/cureus.37832"},{"issue":"1","key":"6451_CR14","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1186\/s12877-023-04229-x","volume":"23","author":"U Elshaikh","year":"2023","unstructured":"Elshaikh U, et al. Barriers and facilitators of older adults for professional mental health help-seeking: a systematic review. BMC Geriatr. 2023;23(1):516.","journal-title":"BMC Geriatr"},{"issue":"11","key":"6451_CR15","doi-asserted-by":"publisher","first-page":"e0207921","DOI":"10.1371\/journal.pone.0207921","volume":"13","author":"CS Estancial Fernandes","year":"2018","unstructured":"Estancial Fernandes CS, et al. Psychotropic use patterns: are there differences between men and women? PLoS ONE. 2018;13(11):e0207921.","journal-title":"PLoS ONE"},{"issue":"12","key":"6451_CR16","doi-asserted-by":"publisher","first-page":"1071","DOI":"10.1016\/S2215-0366(21)00292-3","volume":"8","author":"R Brauer","year":"2021","unstructured":"Brauer R, et al. Psychotropic medicine consumption in 65 countries and regions, 2008\u201319: a longitudinal study. Lancet Psychiatry. 2021;8(12):1071\u201382.","journal-title":"Lancet Psychiatry"},{"key":"6451_CR17","doi-asserted-by":"crossref","unstructured":"Hassan L et al. A cross-sectional prevalence survey of psychotropic medication prescribing patterns in prisons in England. 2015.","DOI":"10.3310\/hsdr02330"},{"key":"6451_CR18","doi-asserted-by":"crossref","unstructured":"McCool A et al. Antidepressant medication prescribing patterns in Irish general practice from 2016 to 2020 to assess for long-term use. Irish Journal of Medical Science (1971-), 2021: pp. 1\u20138.","DOI":"10.1007\/s11845-021-02833-7"},{"key":"6451_CR19","doi-asserted-by":"crossref","unstructured":"Hossain MM et al. Epidemiology of mental health problems in COVID-19: a review. F1000Research, 2020. 9.","DOI":"10.12688\/f1000research.24457.1"},{"key":"6451_CR20","doi-asserted-by":"crossref","unstructured":"Danielson ML. Trends in stimulant prescription fills among commercially insured children and adults\u2014United States, 2016\u20132021. MMWR. Morbidity and mortality weekly report, 2023. 72.","DOI":"10.15585\/mmwr.mm7213a1"},{"issue":"5","key":"6451_CR21","first-page":"467","volume":"119","author":"E Abdelnour","year":"2022","unstructured":"Abdelnour E, Jansen MO, Gold JA. ADHD diagnostic trends: increased recognition or overdiagnosis? Mo Med. 2022;119(5):467.","journal-title":"Mo Med"},{"issue":"8","key":"6451_CR22","doi-asserted-by":"publisher","first-page":"e048528","DOI":"10.1136\/bmjopen-2020-048528","volume":"11","author":"TJ Moore","year":"2021","unstructured":"Moore TJ, et al. Changes in medical use of central nervous system stimulants among US adults, 2013 and 2018: a cross-sectional study. BMJ open. 2021;11(8):e048528.","journal-title":"BMJ open"},{"issue":"3","key":"6451_CR23","doi-asserted-by":"publisher","first-page":"858","DOI":"10.1111\/bcp.13000","volume":"82","author":"C Renoux","year":"2016","unstructured":"Renoux C, et al. Prescribing trends of attention-deficit hyperactivity disorder (ADHD) medications in UK primary care, 1995\u20132015. Br J Clin Pharmacol. 2016;82(3):858\u201368.","journal-title":"Br J Clin Pharmacol"},{"issue":"6","key":"6451_CR24","doi-asserted-by":"publisher","first-page":"1343","DOI":"10.1185\/03007991003772096","volume":"26","author":"D Milea","year":"2010","unstructured":"Milea D, et al. Prescription patterns of antidepressants: findings from a US claims database. Curr Med Res Opin. 2010;26(6):1343\u201353.","journal-title":"Curr Med Res Opin"},{"issue":"2","key":"6451_CR25","doi-asserted-by":"publisher","first-page":"101","DOI":"10.4068\/cmj.2018.54.2.101","volume":"54","author":"S-M Wang","year":"2018","unstructured":"Wang S-M, et al. Addressing the side effects of contemporary antidepressant drugs: a comprehensive review. Chonnam Med J. 2018;54(2):101\u201312.","journal-title":"Chonnam Med J"},{"key":"6451_CR26","first-page":"294","volume":"67","author":"S Maitra","year":"2017","unstructured":"Maitra S, et al. Perioperative gabapentin and Pregabalin in cardiac surgery: a systematic review and meta-analysis. Revista brasileira de anestesiologia. 2017;67:294\u2013304.","journal-title":"Revista brasileira de anestesiologia"},{"issue":"1","key":"6451_CR27","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1002\/jhrm.21262","volume":"37","author":"JJ Savarese","year":"2017","unstructured":"Savarese JJ, Tabler NG Jr. Multimodal analgesia as an alternative to the risks of opioid monotherapy in surgical pain management. J Healthc Risk Manage. 2017;37(1):24\u201330.","journal-title":"J Healthc Risk Manage"},{"key":"6451_CR28","doi-asserted-by":"crossref","unstructured":"Puspitasari IM et al. Medication profile and treatment cost estimation among outpatients with schizophrenia, bipolar disorder, depression, and anxiety disorders in Indonesia. Neuropsychiatr Dis Treat, 2020: pp. 815\u201328.","DOI":"10.2147\/NDT.S240058"},{"issue":"1","key":"6451_CR29","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1080\/09638237.2021.1922632","volume":"32","author":"ES Jami","year":"2023","unstructured":"Jami ES, et al. Antidepressant and antipsychotic treatment of psychotic Major Depression in a British mental healthcare setting. J Mental Health. 2023;32(1):71\u20137.","journal-title":"J Mental Health"},{"issue":"3","key":"6451_CR30","first-page":"e382","volume":"14","author":"A Sabahi","year":"2014","unstructured":"Sabahi A, et al. Patterns of psychotropic medication prescriptions by psychiatrists for private clinic outpatients in Kerman province, Iran. Sultan Qaboos Univ Med J. 2014;14(3):e382.","journal-title":"Sultan Qaboos Univ Med J"},{"issue":"2","key":"6451_CR31","doi-asserted-by":"publisher","first-page":"78","DOI":"10.3109\/13651500903447810","volume":"14","author":"J Donoghue","year":"2010","unstructured":"Donoghue J, Lader M. Usage of benzodiazepines: a review. Int J Psychiatry Clin Pract. 2010;14(2):78\u201387.","journal-title":"Int J Psychiatry Clin Pract"}],"container-title":["BMC Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12888-024-06451-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12888-024-06451-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12888-024-06451-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,3]],"date-time":"2025-01-03T05:04:30Z","timestamp":1735880670000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcpsychiatry.biomedcentral.com\/articles\/10.1186\/s12888-024-06451-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,3]]},"references-count":31,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["6451"],"URL":"https:\/\/doi.org\/10.1186\/s12888-024-06451-2","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-4766476\/v1","asserted-by":"object"}]},"ISSN":["1471-244X"],"issn-type":[{"value":"1471-244X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,3]]},"assertion":[{"value":"19 July 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 December 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 January 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The ethics review board of Tabriz University of Medical Science endorsed the investigation with the ethical code IR.TBZMED.REC.1402.284. The ethics review board had the discretion to waive the requirement for human participant consent in this database study, as it was anonymous and retrospective in nature. In compliance with social security insurance legislation, the insured\u2019s medical information may be employed in research studies. The procedures employed in this investigation were consistent with the principles of the Declaration of Helsinki.\n                      \n                      is the address of the online version of the statement, which is accessible to the public.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Despite the fact that authors made use of advanced large language models (LLMs) like ChatGPT, Copilot (Bing AI) and writing platform (Quillbot) to help assess linguistic quality and assist in utilization of data analysis software such as Excel and SPSS, it was ultimately the authors who conducted the analysis and interpretation of the results.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Statement"}},{"value":"The authors declare no competing interests.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"10"}}